We support pharmaceutical and medtech companies across the full life of a therapy.
Cascador/moveUP supports pharmaceutical and medtech companies across the full life of a therapy: capturing the outcomes that carry clinical trials, helping the right patients start and remain on the right treatment once it reaches the market, and turning every program into the real-world evidence that payers, prescribers and regulators ask for next. We build regulated medical device software, with clinical delivery under good clinical practice and a senior team that stays on the program.
Every program is designed to generate real-world evidence while it runs.
Programs are built around what patients can sustain between consultations, which is what decides whether the data arrives at all.
We hold medical device certification for specific products, ISO 27001 information security certification and a quality system for clinical delivery under GCP. Which of these applies to a given program depends on what that program does, and each one states its own status.
The same evidence base serves the clinician in the consultation and the sponsor in the dossier.
The team that designs a program is the team that delivers it.
Cascador Health and moveUP completed their merger on 3 June 2026 and now operate as one company, on one accredited platform. Existing programs, contracts and contacts continue unchanged.
